Cannabis Law Report

DECEMBER 1, 2021

BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan by delaying aging, today announced that it will participate in two investor conferences during the month of December 2021. MyMD Pharmaceuticals, Inc.

Pharmaceutical 52

Pharmaceutical Clinical Trials Chronic Pain Therapy 52

Veriheal

FEBRUARY 21, 2023

Despite notable advances in MMJ research over the last decade, scientists have found that some states’ restrictions on qualifying conditions prevent millions of patients from getting the treatments they need—robbing them of potential relief offered by cannabinoid therapies.

Access 98

Access Patients Chronic Pain Conditions 98

SpeedWeed

JUNE 15, 2021

The British cannabis pharmaceutical company takes home an award that demonstrates how important cannabis has been to the British economy for over 20 years—but also how much it so far has been reserved, as an industry, and as a drug, for the elite. GW Pharmaceuticals was just awarded a so-called “ Queen’s Prize for Innovation.” .

Pharmaceutical 40

Pharmaceutical Chronic Pain Epilepsy Patients 40

Cannabis Law Report

DECEMBER 28, 2021

–(BUSINESS WIRE)– #pharma –Virpax ® Pharmaceuticals, Inc. (“Virpax” or the “Company”) (NASDAQ:VRPX) achieved significant milestones relating to its pipeline of product candidates as of the end of 2021, which are summarized below. “I BERWYN, Pa.–(BUSINESS

Pharmaceutical 52

Pharmaceutical Research and Development Clinical Trials Chronic Pain 52

PrestoDoctor

OCTOBER 13, 2023

Marinol, also known as Dronabinol, is a medication used to treat a variety of conditions, including nausea and vomiting caused by chemotherapy, loss of appetite and weight loss in people with HIV/AIDS, as well as chronic pain. However, unlike marijuana, Marinol is a FDA-approved pharmaceutical drug.

THC 98

THC Chronic Pain Treatment Conditions 98

Cannabis Law Report

OCTOBER 19, 2021

BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan, announced today that it will present at the Dawson James Securities 6th Annual Small Cap Growth Conference on Thursday, October 21, 2021, at 4:30 p.m.

Pharmaceutical 52

Pharmaceutical Therapy Clinical Trials Chronic Pain 52

Cannabis Law Report

JANUARY 5, 2022

BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan by delaying aging, announced that the U.S. About MyMD Pharmaceuticals, Inc. MyMD Pharmaceuticals, Inc.

Pharmaceutical 52

Pharmaceutical Clinical Trials Therapy Treatment 52

United Patients Group

APRIL 18, 2023

Because they often combine it with other drugs like cocaine or heroin or even legal ‘prescribed’ pharmaceuticals–and those are far more dangerous than cannabis itself! For example, if you have chronic pain and want relief from muscle spasms and stiffness in your joints, then an indica strain may be best for you.

Research and Development 110

Research and Development Indica Treatment Conditions 110

Cannabis Law Report

NOVEMBER 23, 2021

BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan by delaying aging, announced that the U.S. About MyMD Pharmaceuticals, Inc. MyMD Pharmaceuticals, Inc.

Pharmaceutical 52

Pharmaceutical Clinical Trials Therapy Chronic Pain 52

Cannabis Law Report

NOVEMBER 15, 2021

–(BUSINESS WIRE)– #earnings — Virpax ® Pharmaceuticals, Inc. We continue to enhance our product pipeline, and because of our unique delivery technologies we have expanded our targeted indications beyond pain to include Central Nervous System (CNS) disorders and anti-viral indications. “Our RECENT DEVELOPMENTS.

Pharmaceutical 52

Pharmaceutical Research and Development Clinical Trials Chronic Pain 52

Cannabis Law Report

SEPTEMBER 6, 2021

GW Pharmaceuticals. Cannabis is safer and has less severe side effects in comparison to other treatment options. It also finds usage along with other treatments either to enhance their efficacy or to combat adverse side effects. GW Pharmaceuticals. Chronic Pain. during 2021-2026. Companies Mentioned.

Chronic Pain 86

Chronic Pain Research and Development Clinical Trials Epilepsy 86

Cannabis Law Report

SEPTEMBER 20, 2021

–(BUSINESS WIRE)– #pharma — Virpax ® Pharmaceuticals, Inc. Nanomerics”) to use Nanomeric’s molecular envelope platform technology (MET) for the nasal delivery of a cannabidiol (CBD) for the management of epilepsy in adults and children. About Virpax Pharmaceuticals.

Epilepsy 52

Epilepsy Research and Development Clinical Trials Chronic Pain 52

Veriheal

MAY 31, 2022

With a worsening opioid situation and an emerging acceptance of medical cannabis, the Lone Star State has a unique opportunity to develop a successful medical marijuana (MMJ) program for its millions of residents battling chronic pain and numerous other conditions. A Better Alternative for Chronic Pain.

Programs 52

Programs Chronic Pain Treatment Conditions 52

Cannabis Law Report

NOVEMBER 16, 2021

BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan by delaying aging, announced today that it has received U.S. About MyMD Pharmaceuticals, Inc. MyMD Pharmaceuticals, Inc.

Pharmaceutical 52

Pharmaceutical Clinical Trials Research and Development Therapy 52

Cannabis Law Report

SEPTEMBER 13, 2021

BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan, today announced that it intends to initiate dosing for a Phase 2 trial of MYMD-1’s function in delaying aging early in the fourth quarter of 2021.

Clinical Trials 52

Clinical Trials Pharmaceutical Research and Development Therapy 52

Veriheal

AUGUST 9, 2023

CBD, Trema micrantha, and the Study’s Significance CBD means cannabidiol , one of over a hundred compounds in the cannabis plant, and is widely celebrated as a potential treatment for a long list of health concerns, including chronic pain , epilepsy , i nsomnia , anxiety , and skin allergy.

CBD 93

CBD Cannabinoids THC Extraction 93

The Cannigma

JUNE 25, 2022

Patients must have a doctor’s prescription as well as permission from a regional pharmaceutical inspector to obtain cannabis products. Qualifying conditions include chronic pain, multiple sclerosis, spasticity, chemo-induced nausea, and treatment-resistant epilepsy. Poland’s medical cannabis program.

Legalization 108

Legalization Supply Chain Chronic Pain Tincture 108

Cannabis Law Report

OCTOBER 26, 2021

BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan, announced today that Chris Chapman, M.D., Chapman has operated Chapman Pharmaceutical Consulting, Inc., About MyMD Pharmaceuticals, Inc.

Pharmaceutical 52

Pharmaceutical Clinical Trials Research and Development Therapy 52

MMJ Recs

MAY 15, 2022

This initial MMJ legislation only allowed patients suffering from intractable epilepsy to use cannabis oil. Medical marijuana products are produced and sold in Virginia by businesses called “pharmaceutical processors”. You can obtain medical marijuana in Virginia at one of the state’s five licensed pharmaceutical processors.

Patients 52

Patients Marijuana Pharmaceutical Dispensary 52

Cannabis Law Report

AUGUST 2, 2021

Study Results Indicate SCI-160 Has A Significant Analgesic Effect on Acute and Chronic Pain. Daily injections of SCI-160 significantly alleviate pain in a hind paw incision model of post-surgical pain up to 4 days post surgery as compared with vehicle treated animals. TEL AVIV, Israel , Aug. ” About The Study.

Research and Development 105

Research and Development Clinical Trials Treatment Pharmaceutical 105

MMJ Recs

JANUARY 6, 2024

Capsules and pills provide a familiar oral ingestion method, akin to traditional pharmaceuticals. Each type of MMJ product caters to different preferences, medical conditions, and lifestyle choices, ensuring that patients have diverse options for incorporating medical marijuana into their treatment plans.

Chronic Pain 52

Chronic Pain Topical Marijuana Indica 52

Otherside Farms

APRIL 13, 2019

Medical cannabis has been looked to as an alternative source of treatment for a number of ailments due to the healing components of the chemical compounds contained within the wonder plant. Medical cannabis offers an alternative form of pain treatment that isn’t physically habit-forming. Chronic Pain Management.

Chronic Pain 63

Chronic Pain Marijuana Treatment Consumption 63

United Patients Group

FEBRUARY 2, 2023

The ECS has been studied for its role in many diseases including cancer , epilepsy, chronic pain and multiple sclerosis (MS). Cannabis has been shown in several studies to improve the quality of sleep and reduce daytime drowsiness for people who suffer from chronic pain. antibiotics).

Blood Pressure 104

Blood Pressure Sleep Chronic Pain Digestion 104

MMJ Recs

FEBRUARY 3, 2024

In Philadelphia, patients must be diagnosed with specific medical conditions to be eligible for medical cannabis treatment. Common qualifying conditions include: Chronic pain Cancer Epilepsy Post-traumatic stress disorder (PTSD) Understanding the eligibility criteria is essential for patients seeking relief through medical marijuana.

Legislation 52

Legislation Law Marijuana Dispensary 52

Veriheal

DECEMBER 28, 2021

Chronic pain. The report authors noted that THC, on the other hand, is touted as a popular option for alleviating the negative effects of AIDS and cancer treatment. For example, pharmaceutical-grade cannabis is being sold across the fast-evolving retail pharmacy landscape. Amyotrophic lateral sclerosis (ALS). Depression.

Research and Development 98

Research and Development Chronic Pain Treatment Medicine 98

Cannabis Law Report

SEPTEMBER 9, 2021

Medical cannabis is used for the treatment of various chronic conditions, such as Parkinson’s disease, Alzheimer’s disease, arthritis, cancer, depression, anxiety, epilepsy, and other neurological conditions. Chronic Pain. GW Pharmaceuticals, PLC. Segment Dashboard. Medical Use. Tourette’s.

Recreational 95

Recreational Hemp THC Legalization 95

Cannabis Law Report

JANUARY 3, 2022

TASE: PNAX), a global pharma company that develops, manufactures and markets progressive cannabis-based products in pharmaceutical quality, announced today that it has received official approval for the EU-GMP standard for its production facility in Malta from EU Health Authority. SOURCE Panaxia Pharmaceutical Industries.

Pharmaceutical 52

Pharmaceutical Chronic Pain Extraction Epilepsy 52

Veriheal

MAY 17, 2021

Please don’t further the lie by voting for any form of legalization beyond the pharmaceutical remedies already available under state law.” That is perhaps the biggest lie that is being perpetuated on the Alabama public today. ” State Doctors Oppose Legalization in Alabama.

Legalization 86

Legalization Pharmaceutical Therapy Chronic Pain 86

MMJ Recs

NOVEMBER 7, 2022

If the Registered Practitioner for Medical Cannabis decides you can benefit from medical marijuana treatment, they will write you a Certification for the Use of Medical Cannabis. The most common medical conditions that patients are prescribed MMJ treatment for in Virginia are: Alzheimer’s Disease. Chronic Pain.

Marijuana 52

Marijuana Chronic Pain Dispensary Pharmaceutical 52

Otherside Farms

NOVEMBER 26, 2020

Reports show that CBD has the potential to treat insomnia, spasticity, anxiety, indigestion, the pain of all types and can even be used as an adjunct treatment for life-threatening cases of epilepsy. This makes it beneficial to those who can’t take regular pain meds due to kidney conditions or GERD.

Marijuana 52

Marijuana Epilepsy Chronic Pain Treatment 52

CannaTech

JANUARY 16, 2019

Pharmaceutical grade cannabis is relatively new in parts of the world. Patients, and their treatment, therefore, are the priority. Treatment options may be limited by government-approved imports, a practitioner’s prescription or pharmacy stock. It is not a story about profiting off of people. million people.

Access 89

Access Patients Pharmaceutical Education 89

MGC Pharma

FEBRUARY 20, 2018

The Top Medical Cannabis Research of 2017 A word from Ron Lipsky, Manager of Business Development and International Relations at MGC Pharmaceuticals MGC Pharma is still riding off the success of 2017 as we progress into 2018, with many exciting developments on the horizon.

Research and Development 100

Research and Development Clinical Trials Patients Chronic Pain 100

Cannabis Law Report

DECEMBER 8, 2021

–(BUSINESS WIRE)– #pharma — Virpax ® Pharmaceuticals, Inc. Single-dose transdermal delivery of Epoladerm was well-tolerated in all minipigs and no treatment-related clinical observations, changes in body weight, or dermal irritation were observed. About Virpax Pharmaceuticals. BERWYN, Pa.–(BUSINESS

Clinical Trials 52

Clinical Trials Chronic Pain Pharmaceutical Topical 52

MMJ Recs

FEBRUARY 18, 2021

Millions of patients all across the nation are now seeing a massive improvement in their quality of life thanks to MMJ treatment. Medical marijuana is being used in the US to treat a wide variety of illnesses, such as chronic pain, glaucoma, migraine, muscle spasms, insomnia, arthritis, PTSD, and epilepsy.

Legalization 52

Legalization Marijuana Treatment Programs 52

Veriheal

JULY 21, 2022

On July 1, the process of procuring pharmaceutical-approved cannabis was simplified for individuals residing across the state, where the first licensed medical marijuana dispensary opened its doors in August 2020. Chronic pain. Epilepsy / seizure disorders. Amyotrophic Lateral Sclerosis (ALS) . Crohn’s disease.

Access 104

Access Dispensary Patients Programs 104

Cannabis Law Report

JANUARY 15, 2020

The fulfilment, which has been prescribed to Jorja Emerson, a three-year-old British girl who suffers from severe epilepsy, demonstrates a real progression in the quest to allow patients to access pioneering treatments of Medical Cannabis. Cannaray today announces the fulfilment of its first Medical Cannabis prescription in the UK.

CBD 64

CBD Epilepsy Chronic Pain Treatment 64

Veriheal

NOVEMBER 10, 2020

The experiment will allow participating companies to import cannabis and the companies who wish to participate in the experiment will be obliged to give participants free medical cannabis which has to comply with the pharmaceutical standards and good manufacturing practice. .

Chronic Pain 76

Chronic Pain Pharmaceutical Patients Epilepsy 76